Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3
Sabine Nuding(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Eduard F. Stange(John Radcliffe Hospital), Edith Porter(California State University Los Angeles), Lutz Zabel(Alb Fils Kliniken), Corinne Enders(Ardeypharm (Germany)), Holger A.G. Mueller(Alb Fils Kliniken), Jan Wehkamp(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel))
Cited by 52
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558